Insider trading

Period: 120 months Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

312,610 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

312,610 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

312,610 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

312,610 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
312,610 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
312,610 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

312,610 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 Feb 2026
Lawton Patrick S Director
Sold at will
$555.90K 30,000 at 18.53
60.9%
Sold half or more
3 Feb 2026
Hunsaker Craig E EVP, PEOPLE & CULTURE
Sold on a plan
$549.54K 37,358 at 14.71
3.1%
Planned (10b5-1)
3 Feb 2026
Staley Gary W SVP Global Sales NSE
Sold at will
$537.63K 20,742 at 25.92
10.2%
Not planned
3 Feb 2026
Volk David J. Director
Bought
$503.28K 27,000 at 18.64
×23
First buy on file
3 Feb 2026
Lewis William Chair and CEO
Sold at will
$470.43K 3,009 at 156.34
1.0%
Not planned
3 Feb 2026
Naude Pierre Director
Sold at will
$453.47K 24,273 at 18.68
2.0%
Not planned
3 Feb 2026
BALAKRISHNAN BALU Director · indirect
Sold at will 2×
$451.11K 10,080 at 44.75
1.7%
Not planned
3 Feb 2026
ROTE WILLIAM E. Chief Research Officer
Sold on a plan
$409.10K 12,446 at 32.87
10.2%
Planned (10b5-1)
3 Feb 2026
BENDHEIM JACK President and CEO · indirect
Sold on a plan 2×
$400.61K 9,660 at 41.47
30.2%
Planned (10b5-1)
3 Feb 2026
Williams Michael S Chief Executive Officer
Sold on a plan
$399.93K 19,017 at 21.03
2.7%
Planned (10b5-1)
3 Feb 2026
Kellermann Kimberly Anne SVP, Chief Operations Officer
Sold at will
$379.03K 5,265 at 71.99
47.5%
Not planned
3 Feb 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$378.23K 1,639 at 230.77
1.2%
Planned (10b5-1)
3 Feb 2026
Weber Barbara Director, Executive Chair
Sold at will 2×
$374.29K 30,519 at 12.26
1.8%
Not planned
3 Feb 2026
Williams James P SVP-CHRO
Sold at will
$352.17K 5,243 at 67.17
9.7%
Not planned
3 Feb 2026
Tapiero Jacques Director
Sold at will
$319.25K 5,000 at 63.85
13.7%
Not planned
3 Feb 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$307.84K 1,334 at 230.77
0.6%
Planned (10b5-1)
3 Feb 2026
Desmond Sean CEO & President
Sold at will
$299.79K 16,047 at 18.68
2.6%
Not planned
3 Feb 2026
Capel Mary Clara Retired Board Member
Sold at will
$296.55K 5,000 at 59.31
19.7%
Not planned
3 Feb 2026
Bos Teresa D. 10% owner
Sold at will
$296.21K 20,889 at 14.18
1.9%
Not planned
3 Feb 2026
Chaney Brian K Senior Vice President
Sold at will
$288.04K 11,157 at 25.82
11.2%
Not planned
3 Feb 2026
Fauber Robert President and CEO
Sold on a plan
$286.87K 575 at 498.90
0.9%
Planned (10b5-1)
3 Feb 2026
Sold at will
$261.23K 7,500 at 34.83
0.7%
Not planned
3 Feb 2026
STEELE SALLY A Director
Sold at will
$256.48K 4,000 at 64.12
9.1%
Not planned
3 Feb 2026
FITZSIMMONS PETER D President and CEO
Bought
$251.02K 13,350 at 18.80
15.5%
First buy on file
3 Feb 2026
Procacci Riccardo Senior Vice President
Sold at will
$248.09K 800 at 310.11
4.8%
Not planned
3 Feb 2026
NAKAHARA ASUKA Director
Sold at will
$245.77K 8,275 at 29.70
12.5%
Not planned
3 Feb 2026
FOLGER ANTHONY Chief Financial Officer
Sold on a plan 2×
$240.01K 6,000 at 40.00
10.9%
Planned (10b5-1)
3 Feb 2026
Heerma Peter CHIEF COMMERCIAL OFFICER
Sold at will
$234.80K 7,310 at 32.12
5.3%
Not planned
3 Feb 2026
Leproust Emily M. Chief Executive Officer
Sold at will
$232.93K 5,001 at 46.58
0.6%
Not planned
3 Feb 2026
Cline Christopher R. CHIEF FINANCIAL OFFICER
Sold at will
$232.61K 7,242 at 32.12
6.0%
Not planned
3 Feb 2026
REED ELIZABETH E Chief Legal Officer and GC
Sold at will
$230.46K 7,175 at 32.12
6.2%
Not planned
3 Feb 2026
Crystal Adam President, R&D
Sold at will 2×
$226.30K 18,452 at 12.26
9.0%
Not planned
3 Feb 2026
Walsh Kenneth M Director
Sold at will
$224.72K 10,000 at 22.47
9.8%
Not planned
3 Feb 2026
Inrig Jula CHIEF MEDICAL OFFICER
Sold at will
$223.43K 6,956 at 32.12
6.1%
Not planned
3 Feb 2026
Duncan David R Director · indirect
Sold at will 3×
$220.51K 8,626 at 25.56
100%
Sold half or more
3 Feb 2026
WALTERS KIRK W Director
Sold at will
$206.68K 909 at 227.37
13.2%
Not planned
3 Feb 2026
Orenstein Gregory CFO & Treasurer
Sold at will
$197.32K 10,562 at 18.68
2.3%
Not planned
3 Feb 2026
Bought 2×
$191.23K 413 at 463.01
2.7%
First buy on file
3 Feb 2026
Sathyanarayanan Bala EVP, Chief Human Resources Off
Sold at will
$180.65K 2,499 at 72.29
5.0%
Not planned
3 Feb 2026
Remer Eric Richard Chief Executive Officer
Sold on a plan 2×
$178.87K 16,403 at 10.90
0.6%
Planned (10b5-1)
3 Feb 2026
Singh Ritadhwaja Jebens EVP & CHIEF DIGITAL OFFICER
Sold on a plan
$178.22K 5,880 at 30.31
5.4%
Planned (10b5-1)
3 Feb 2026
Yu Gary President and CEO
Sold at will
$176.47K 2,900 at 60.85
2.5%
Not planned
3 Feb 2026
Richards Jay D. Officer of Subsidiary
Sold at will
$174.70K 3,506 at 49.83
8.9%
Not planned
3 Feb 2026
Takao Justin Treasurer, CAO & CFO
Sold at will 3×
$173.47K 14,807 at 11.72
69.6%
Sold half or more
3 Feb 2026
Sold at will
$156.31K 11,000 at 14.21
64.0%
Sold half or more
3 Feb 2026
ROBINS HARLAN S Chief Scientific Officer
Sold on a plan
$154.28K 8,120 at 19.00
0.7%
Planned (10b5-1)
3 Feb 2026
Rieger April Chief Lgl. & Admin Ofc., Sec
Sold at will
$150.91K 8,078 at 18.68
3.5%
Not planned
3 Feb 2026
Claussen James J Executive Vice President & CFO
Sold on a plan
$149.16K 4,972 at 30.00
6.3%
Planned (10b5-1)
3 Feb 2026
FISHER ERIKA ASHLEY Chief Legal Officer
Sold on a plan
$148.36K 589 at 251.88
5.1%
Planned (10b5-1)
3 Feb 2026
Smith Jason Drew General Counsel
Sold at will 3×
$147.26K 7,479 at 19.69
12.7%
Not planned
Showing 27,851–27,900 of 312,610. ← Newer Page 558 of 6,253 Older →